Drugs / BAY1003803
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02936492 | Oct 2016 → Apr 2017 | psoriasis | Bayer | Terminated | No outcome recorded |
| Phase 1 | NCT02940002 | Oct 2016 → Jan 2017 | psoriasis | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1003803 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02940002 ↗ |
| Route | Topical | “BAY1003803 0.1% lipophilic cream (on plaque and healthy skin)” NCT02940002 ↗ |